Mackenzie Financial Corp Raises Holdings in Teladoc Health, Inc. (NYSE:TDOC)

Mackenzie Financial Corp lifted its position in Teladoc Health, Inc. (NYSE:TDOC - Free Report) by 170.7% in the second quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 107,255 shares of the health services provider's stock after buying an additional 67,640 shares during the period. Mackenzie Financial Corp owned about 0.06% of Teladoc Health worth $1,049,000 as of its most recent SEC filing.

Other large investors have also made changes to their positions in the company. Vanguard Group Inc. increased its holdings in Teladoc Health by 11.8% during the 4th quarter. Vanguard Group Inc. now owns 17,515,127 shares of the health services provider's stock worth $377,451,000 after purchasing an additional 1,855,480 shares in the last quarter. Point72 Asset Management L.P. grew its holdings in shares of Teladoc Health by 221.9% in the 2nd quarter. Point72 Asset Management L.P. now owns 5,303,123 shares of the health services provider's stock valued at $51,865,000 after acquiring an additional 3,655,436 shares in the last quarter. Rubric Capital Management LP bought a new position in shares of Teladoc Health in the 2nd quarter valued at about $45,267,000. Bank of New York Mellon Corp grew its holdings in shares of Teladoc Health by 1.7% in the 2nd quarter. Bank of New York Mellon Corp now owns 916,129 shares of the health services provider's stock valued at $8,960,000 after acquiring an additional 14,910 shares in the last quarter. Finally, AQR Capital Management LLC grew its holdings in shares of Teladoc Health by 9.1% in the 2nd quarter. AQR Capital Management LLC now owns 675,707 shares of the health services provider's stock valued at $6,608,000 after acquiring an additional 56,202 shares in the last quarter. Institutional investors own 76.82% of the company's stock.

Insider Buying and Selling at Teladoc Health

In related news, insider Vidya Raman-Tangella sold 3,857 shares of Teladoc Health stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares of the company's stock, valued at $274,049.38. The trade was a 0.00 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In other news, Director Thomas Mckinley bought 4,000 shares of the stock in a transaction dated Thursday, September 12th. The shares were bought at an average cost of $7.69 per share, with a total value of $30,760.00. Following the completion of the transaction, the director now directly owns 39,077 shares of the company's stock, valued at $300,502.13. This trade represents a 0.00 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Vidya Raman-Tangella sold 3,857 shares of the company's stock in a transaction that occurred on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total value of $31,395.98. Following the transaction, the insider now directly owns 33,667 shares in the company, valued at $274,049.38. The trade was a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 57,377 shares of company stock worth $438,054. Insiders own 0.95% of the company's stock.

Analyst Ratings Changes

Several brokerages have recently weighed in on TDOC. Deutsche Bank Aktiengesellschaft decreased their price objective on Teladoc Health from $15.00 to $10.00 and set a "hold" rating for the company in a report on Friday, August 2nd. JPMorgan Chase & Co. decreased their price objective on Teladoc Health from $16.00 to $9.00 and set a "neutral" rating for the company in a report on Monday, August 26th. TD Cowen decreased their price objective on Teladoc Health from $15.00 to $9.00 and set a "hold" rating for the company in a report on Thursday, August 1st. Piper Sandler cut their target price on shares of Teladoc Health from $25.00 to $10.00 and set an "overweight" rating for the company in a research note on Tuesday, August 6th. Finally, Oppenheimer cut their target price on shares of Teladoc Health from $21.00 to $17.00 and set an "outperform" rating for the company in a research note on Thursday, August 1st. Fifteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company's stock. According to MarketBeat, the stock currently has a consensus rating of "Hold" and a consensus target price of $12.31.

Teladoc Health Price Performance

Shares of NYSE TDOC traded up $0.36 during midday trading on Friday, reaching $9.04. 2,507,831 shares of the company were exchanged, compared to its average volume of 5,508,445. The stock's 50-day moving average price is $7.90 and its 200-day moving average price is $10.51. The stock has a market cap of $1.53 billion, a P/E ratio of -6.30 and a beta of 0.90. Teladoc Health, Inc. has a one year low of $6.76 and a one year high of $22.54. The company has a quick ratio of 1.62, a current ratio of 1.66 and a debt-to-equity ratio of 0.66.

Teladoc Health (NYSE:TDOC - Get Free Report) last posted its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, topping analysts' consensus estimates of ($0.36) by $0.08. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. The firm had revenue of $642.44 million for the quarter, compared to analysts' expectations of $649.34 million. On average, sell-side analysts anticipate that Teladoc Health, Inc. will post -1.18 earnings per share for the current fiscal year.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.